Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Inzicht in immuunmetabolisme biedt nieuwe aanknopingspunten voor behandelstrategie pneumonie
jul 2022 | Pneumonie